Lack of Survival Benefit with Immunotherapy in Combination with Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-small Cell Lung Cancer.
Saved in:
| Title: | Lack of Survival Benefit with Immunotherapy in Combination with Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-small Cell Lung Cancer. |
|---|---|
| Authors: | Venugopal N; Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA., Vazquez-Urrutia JR; Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA., Zhu J; Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA., Hashinokuchi A; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Takamori S; Department of Surgery and Science, Graduate School of Medical Sciences, Kyusyu University, Fukuoka, Japan., Komiya T; Division of Hematology Oncology, Penn State College of Medicine, Hershey, PA, USA. tkomiya@pennstatehealth.psu.edu. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Oct; Vol. 32 (10), pp. 7883-7890. Date of Electronic Publication: 2025 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1534-4681 |
|---|---|
| DOI: | 10.1245/s10434-025-17766-z |
